期刊文献+

携带tPA基因转移的真核表达载体的构建研究 被引量:2

Construction of pcDNA3.1(+) tPA experession vector
下载PDF
导出
摘要 目的 构建一种无形成病毒及激活原癌基因之虞的真核表达载体pcDNA3.1(+ )tPA,以探讨其对纤溶活性的影响。方法 用分子克隆方法,将人tPA cDNA 与真核表达载体pcDNA3.1(+ )重组,并对重组质粒进行DNA 测序。结果 重组质粒pcDNA3.1(+ )tPA 经K pnI和XbaI酶切后,出现了5.4kb 与 2.0kb 两个片段;经PstI酶切后出现了 78bp,414bp,622bp,2.0Kb 及4.2Kb 五个片段;经EcoRI酶切后,出现了472bp 及6.9Kb 两个片段;测序结果证明为人全长tPA cDNA。结论 该新型表达质粒的构建为探讨基因防治脑梗塞等血栓性疾病提供了新工具。 Objective To construct a new kind of recombinant vector containing human tissue type plasminogen activator(t PA) cDNA for studing the feasibility of enhancing fibrinolytic activity by transplantation of genetic engineering cells.Methods We recombinated human tPA cDNA with expression vector pcDNA3.1(+) by using the method of molecular cloning,sequenced the plasmid DNA,and cut the plasmid by using enzymes.Results The plasmid pcDNA3.1(+)tPA was divided into 5.4Kb and 2.0Kb segments respectively by using Kpn I and Xba I,into 78bp,414bp,822bp,2.0Kb,and 4.2Kb segments respectively by using Pst I,into 472bp and 6.9Kb segments respectively by using EcoR I.Sequenoling result showed that it is the whole human tPA cDNA.Conclusions The new kind of recombinant expression vector could serve as new tools and methods for prevention of thrombogenic diseases. [
出处 《中国地方病学杂志》 CAS CSCD 1999年第6期401-403,共3页 Chinese Jouranl of Endemiology
基金 国家自然科学基金 哈尔滨市学科后备带头人基金
关键词 真核表达载体 组织型 纤溶酶原激活剂 基因转移 tPA gene transfer Recombinant expression vector
  • 相关文献

参考文献1

  • 1Acsadi G,New Biologist,1991年,3期,71页

同被引文献27

  • 1吴忠均,陈地龙,石正洪,李德卫,郑树森,时德.人tPA基因真核表达质粒载体构建及其生物学功能研究[J].兰州大学学报(自然科学版),2006,42(2):34-37. 被引量:2
  • 2牛明福,李翔,曹瑞兵,郑其升,魏建超,姬向波,李鹏,周斌,陈溥言.共表达猪繁殖与呼吸综合征病毒GP5基因及猪γ-干扰素基因的腺病毒载体的构建与鉴定[J].中国生物工程杂志,2007,27(1):35-40. 被引量:3
  • 3RAPP J C, HARVEY A J, SPEKSNIJDER G L, et al. Biologically active human interferon α- 2b produced in the egg white of transgenie hens[J]. Transgenie research, 2003,12 : 569 - 575.
  • 4RAJU T S, BRIGGS J B, BORGE S M, et al. Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics[J]. Glycobiology, 2000,10:477 -486.
  • 5MOZDZIAK P E, BORWORNPINYO S, McCoy D W, et al. Development of transgenic chickens expressing bacterial β-galactosidase[J]. Developmental Dynamics, 2003,226: 439 - 445.
  • 6DULL T, ZUFFEREY R, MANDEL R J, et al. A third generation lentivirus vector with a conditional packaging system[J]. J Viral, 1998, 72:84631.
  • 7LINEOFF A M, TOPOL E J. Illusion of reperfusion. Does anyone achieve optimal reperfusion during dcute myocardial infarction? Circulation, 1993,88(8) : 1361 - 1374.
  • 8ALBERTS M J. tPA in acute ischemic stroke: United States experience and issues for the futute. Neurology, 1998,51 : S53 - S54.
  • 9FAGAN S C, MORGENSTERN L B, A Petitta, et al. Cost-effectiveness of tissue plasminogen activator for acute ischem ic stroke[J]. American Academy Neurology, 1998,50: 883 - 884.
  • 10WEITZ J I, STEWART R, FREDENBUHGR J C. Mechanism of action of plasminogen activators[J]. Thrombosis and Haemostasts, 1999,82 ( 1 ) : 974 - 982.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部